21553 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE
#2HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE
#3Heterocyclic compounds for cancer imaging and treatment and methods for their use
#4Heterocyclic compounds for cancer imaging and treatment and methods for their use
#5Alpha-synuclein ligands
#6USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS
#7Heterocyclic molecules for biomedical imaging and therapeutic applications
#8RADIOLABELED PDE10A LIGANDS
#9Highly selective sigma receptor ligands and radioligands as probes in nociceptive processing and the pathphysiological study of memory deficits and cognitive disorders
#103,7-diamino-10H-phenothiazine salts and their use
#11Precursor compound connected to solid support for manufacturing 18F radiopharmaceutical, method for manufacturing same, and application thereof
#12Radiolabeled PDE10A ligands
#13TRICYCLIC HETEROAROMATIC COMPOUNDS AS ALPHA-SYNUCLEIN LIGANDS
#14DIAGNOSTIC PROBE FOR CONFORMATION DISEASE
#153,7-diamino-10H-phenothiazine salts and their use
#16PET PROBE HAVING AN ALKOXY GROUP SUBSTITUTED BY FLUORINE AND HYDROXY GROUP
#17Radiolabeled lymphatic staining agents and methods for making
#18Benzoxazole derivatives
#19Inhibitors of protein aggregation
#20DIAGNOSTIC PROBE FOR CONFORMATION DISEASE
#21PIPERAZINYL AND DIAZAPANYL BENZAMIDES AND BENZTHIOAMIDES
#22Radiolabeled lymphatic staining agents and methods for making
#23Novel chemical agents comprising a cardiotonic moiety and an imaging moiety and methods of their use